JP2013535209A5 - - Google Patents

Download PDF

Info

Publication number
JP2013535209A5
JP2013535209A5 JP2013522265A JP2013522265A JP2013535209A5 JP 2013535209 A5 JP2013535209 A5 JP 2013535209A5 JP 2013522265 A JP2013522265 A JP 2013522265A JP 2013522265 A JP2013522265 A JP 2013522265A JP 2013535209 A5 JP2013535209 A5 JP 2013535209A5
Authority
JP
Japan
Prior art keywords
cell
seq
primer
nucleic acid
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013522265A
Other languages
English (en)
Japanese (ja)
Other versions
JP6192537B2 (ja
JP2013535209A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2011/063538 external-priority patent/WO2012017081A1/en
Publication of JP2013535209A publication Critical patent/JP2013535209A/ja
Publication of JP2013535209A5 publication Critical patent/JP2013535209A5/ja
Application granted granted Critical
Publication of JP6192537B2 publication Critical patent/JP6192537B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013522265A 2010-08-06 2011-08-05 T細胞の標的抗原の同定 Expired - Fee Related JP6192537B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10008233 2010-08-06
EP10008233.8 2010-08-06
PCT/EP2011/063538 WO2012017081A1 (en) 2010-08-06 2011-08-05 Identification of t cell target antigens

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016197135A Division JP2017038609A (ja) 2010-08-06 2016-10-05 T細胞の標的抗原の同定

Publications (3)

Publication Number Publication Date
JP2013535209A JP2013535209A (ja) 2013-09-12
JP2013535209A5 true JP2013535209A5 (https=) 2014-08-28
JP6192537B2 JP6192537B2 (ja) 2017-09-06

Family

ID=44023005

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013522265A Expired - Fee Related JP6192537B2 (ja) 2010-08-06 2011-08-05 T細胞の標的抗原の同定
JP2016197135A Withdrawn JP2017038609A (ja) 2010-08-06 2016-10-05 T細胞の標的抗原の同定

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016197135A Withdrawn JP2017038609A (ja) 2010-08-06 2016-10-05 T細胞の標的抗原の同定

Country Status (5)

Country Link
US (2) US9678061B2 (https=)
EP (3) EP2601521B1 (https=)
JP (2) JP6192537B2 (https=)
CA (1) CA2806440A1 (https=)
WO (1) WO2012017081A1 (https=)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2387627B1 (en) 2009-01-15 2016-03-30 Adaptive Biotechnologies Corporation Adaptive immunity profiling and methods for generation of monoclonal antibodies
ES2834070T3 (es) 2011-09-15 2021-06-16 Us Health Receptores de células T que reconocen MAGE restringido por HLA-A1 o HLA-Cw7
US9824179B2 (en) * 2011-12-09 2017-11-21 Adaptive Biotechnologies Corp. Diagnosis of lymphoid malignancies and minimal residual disease detection
RU2746407C1 (ru) 2012-02-23 2021-04-13 Стейдж Селл Терапеутикс Гмбх Хроматографическое выделение клеток и других сложных биологических материалов
DK2823060T3 (en) 2012-03-05 2018-05-28 Adaptive Biotechnologies Corp Determination of associated immune receptor chains from frequency-matched subunits
CA2872468C (en) 2012-05-08 2020-10-27 Adaptive Biotechnologies Corporation Compositions and methods for measuring and calibrating amplification bias in multiplexed pcr reactions
US20140065098A1 (en) * 2012-08-29 2014-03-06 Israel Barken Method to augment immune system in response to disease or injury
US20140065629A1 (en) * 2012-08-29 2014-03-06 Israel Barken Methods of treating diseases
US10150996B2 (en) 2012-10-19 2018-12-11 Adaptive Biotechnologies Corp. Quantification of adaptive immune cell genomes in a complex mixture of cells
US20140356318A1 (en) * 2013-05-28 2014-12-04 Israel Barken Adoptive cell therapy with specific regulatory lymphocytes
US9708657B2 (en) 2013-07-01 2017-07-18 Adaptive Biotechnologies Corp. Method for generating clonotype profiles using sequence tags
CN106103711A (zh) 2013-11-21 2016-11-09 组库创世纪株式会社 T细胞受体和b细胞受体库分析系统及其在治疗和诊断中的应用
US10627411B2 (en) 2014-03-27 2020-04-21 British Columbia Cancer Agency Branch T-cell epitope identification
US10066265B2 (en) 2014-04-01 2018-09-04 Adaptive Biotechnologies Corp. Determining antigen-specific t-cells
BR112016024072B1 (pt) 2014-04-16 2021-02-09 Juno Therapeutics Gmbh método in vitro de estimular uma população de células
RU2763795C2 (ru) 2014-04-23 2022-01-11 Джуно Терапьютикс, Инк. Способы выделения, культивирования и генетической инженерии популяций клеток иммунной системы для адоптивной терапии
WO2016014725A1 (en) 2014-07-22 2016-01-28 The University Of Notre Dame Du Lac Molecular constructs and uses thereof
CA2966201A1 (en) 2014-10-29 2016-05-06 Adaptive Biotechnologies Corp. Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from many samples
US10246701B2 (en) 2014-11-14 2019-04-02 Adaptive Biotechnologies Corp. Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture
CA2976580A1 (en) 2015-02-24 2016-09-01 Adaptive Biotechnologies Corp. Methods for diagnosing infectious disease and determining hla status using immune repertoire sequencing
AU2016242967B2 (en) 2015-04-01 2021-07-01 Adaptive Biotechnologies Corp. Method of identifying human compatible T cell receptors specific for an antigenic target
EP3112375A1 (en) 2015-07-03 2017-01-04 Ludwig-Maximilians-Universität München Antigenic peptides for the diagnosis, therapy monitoring and/or treatment of psoriasis vulgaris
JP7341661B2 (ja) * 2015-09-25 2023-09-11 アブビトロ, エルエルシー ネイティブに対合するt細胞受容体配列のt細胞受容体標的識別のための高スループットプロセス
US11248238B2 (en) 2015-10-22 2022-02-15 Juno Therapeutics Gmbh Methods, kits, agents and apparatuses for transduction
SG11201803330WA (en) 2015-10-22 2018-05-30 Juno Therapeutics Gmbh Methods for culturing cells and kits and apparatus for same
JP7194020B2 (ja) 2015-10-22 2022-12-21 ジュノ セラピューティクス ゲーエムベーハー 細胞の培養方法ならびにそのためのキットおよび装置
EP3368691A4 (en) * 2015-10-27 2019-04-03 Arizona Board of Regents on behalf of Arizona State University HIGH-SCREEN-TYPE IDENTIFICATION OF ANTIGENES AND EPITOPES FOR T-CELL DETECTION
CN108884140B (zh) 2015-12-03 2022-10-25 朱诺治疗学股份有限公司 修饰的嵌合受体及相关组合物和方法
US20190227063A1 (en) * 2016-09-16 2019-07-25 Memorial Sloan Kettering Cancer Center Methods and compositions for t-cell epitope screening
US10428325B1 (en) 2016-09-21 2019-10-01 Adaptive Biotechnologies Corporation Identification of antigen-specific B cell receptors
CN110023497B (zh) 2016-11-07 2021-07-13 杰诺维有限公司 用于t细胞受体合成和向tcr呈递细胞进行稳定的基因组整合的两部分装置
EP3535387B1 (en) 2016-11-07 2022-01-12 Genovie AB An engineered multi-component system for identification and characterisation of t-cell receptors and t-cell antigens
KR102606929B1 (ko) * 2016-11-07 2023-11-27 제노비에 에이비 동족 항원과 t-세포 수용체 상호작용의 발견 및 특징규명을 위한 조작된 2-부분 세포 디바이스
JP7339160B2 (ja) 2017-04-27 2023-09-05 ジュノ セラピューティクス ゲーエムベーハー オリゴマー粒子試薬およびその使用方法
WO2018213803A1 (en) * 2017-05-19 2018-11-22 Neon Therapeutics, Inc. Immunogenic neoantigen identification
US20200308279A1 (en) 2017-10-06 2020-10-01 Oslo Universitetssykehus Hf Chimeric antigen receptors
US11254980B1 (en) 2017-11-29 2022-02-22 Adaptive Biotechnologies Corporation Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements
MX2020011023A (es) 2018-04-19 2021-01-29 Baylor College Medicine Reprogramación de células t cd4 en células cd8 citotóxicas por expresión forzada de cd8ab y receptores de células t restringidos de clase 1.
CN113474450A (zh) 2018-08-09 2021-10-01 朱诺治疗学股份有限公司 产生工程化细胞的方法以及所述工程化细胞的组合物
US20210301324A1 (en) * 2018-08-24 2021-09-30 Repertoire Genesis Incorporation Method for analyzing functional subunit pair gene of t cell receptor and b cell receptor
EP3874024A1 (en) 2018-10-31 2021-09-08 Juno Therapeutics GmbH Methods for selection and stimulation of cells and apparatus for same
CN114807125B (zh) * 2022-05-20 2023-09-12 纳昂达(南京)生物科技有限公司 测序文库接头、测序文库及其构建方法、提升ngs建库连接效率的方法
CN121100267A (zh) 2022-12-09 2025-12-09 朱诺治疗学股份有限公司 使用全息成像预测细胞表型的机器学习方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037135A (en) 1992-08-07 2000-03-14 Epimmune Inc. Methods for making HLA binding peptides and their uses
US20010053523A1 (en) * 1995-06-02 2001-12-20 M&E Biotech A/S. Method for identification of biologically active peptides and nucleic acids
JP2000505650A (ja) * 1996-02-08 2000-05-16 アメリカ合衆国 樹状突起細胞を形質転換し、そしてt細胞を活性化するための方法及び組成物
WO1998046739A1 (fr) * 1997-04-16 1998-10-22 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Molecules immunomodulatrices et leur procede de production
US6872518B2 (en) * 1997-09-22 2005-03-29 University Of Rochester Methods for selecting polynucleotides encoding T cell epitopes
DE10009341A1 (de) * 2000-02-22 2001-09-06 Florian Kern Verfahren zur antigen-spezifischen Stimulation von T-Lymphozyten
JP4812951B2 (ja) * 2001-03-21 2011-11-09 一般財団法人化学及血清療法研究所 特異性不明のt細胞のクローン化法及びその認識ペプチドリガンドの同定方法
ATE388448T1 (de) * 2001-04-13 2008-03-15 Inst Nat Sante Rech Med Verfahren zur analyse von t-lymphozyten über die t-lymphozytrezeptoren eines organismus
US20030003485A1 (en) * 2001-05-15 2003-01-02 Ludwig Institute For Cancer Research Methods for identifying antigens
WO2003068800A2 (en) 2002-02-13 2003-08-21 Ludwig Institute For Cancer Research Isolated peptides which bind to hla molecules and uses thereof
JP2009515534A (ja) 2005-11-10 2009-04-16 ザ ユニヴァーシティー オヴ シカゴ Hcv−反応性t細胞受容体
JP5292550B2 (ja) 2007-03-23 2013-09-18 静岡県 T細胞レセプターβ鎖遺伝子及びα鎖遺伝子
GB0712670D0 (en) * 2007-06-29 2007-08-08 King S College London Isolated peptides and uses thereof
US9012148B2 (en) * 2008-04-16 2015-04-21 Jian Han Method for evaluating and comparing immunorepertoires
US7892202B2 (en) 2008-05-09 2011-02-22 Merit Medical Systems, Inc. System and method for inflation syringe with improved display
CN104195227B (zh) * 2008-11-07 2017-04-12 适应生物技术公司 通过序列分析监测状况的方法

Similar Documents

Publication Publication Date Title
JP2013535209A5 (https=)
Liu et al. Applications of immunogenomics to cancer
Naghavian et al. Microbial peptides activate tumour-infiltrating lymphocytes in glioblastoma
JP6918703B2 (ja) がんを治療するための方法
Tubo et al. Single naive CD4+ T cells from a diverse repertoire produce different effector cell types during infection
US9045791B2 (en) Antigen screening system
EP4667567A3 (en) Reagents and methods for molecular barcoding of nucleic acids of single cells
JP2015528443A (ja) 新規マイナー組織適合抗原を同定するための方法
CA3062698A1 (en) Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereof
FI3535290T3 (fi) Keinotekoinen kaksiosainen solulaite T-solun reseptorin vuorovaikutuksen havaitsemiseksi ja luonnehtimiseksi kognaattiantigeenin kanssa
Vigdorovich et al. Repertoire comparison of the B‐cell receptor‐encoding loci in humans and rhesus macaques by next‐generation sequencing
WO2019231856A1 (en) Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples
CA3213002A1 (en) Transmembrane neoantigenic peptides
JP2013521789A5 (https=)
Rieder et al. Experimental tools to identify RNA-protein interactions in Helicobacter pylori
US20240110311A1 (en) Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples
Schwarz et al. T cells of colorectal cancer patients’ stimulated by neoantigenic and cryptic peptides better recognize autologous tumor cells
JP2014521316A5 (https=)
RU2014102617A (ru) Выявление аффинно-зрелых человеческих антител
JP2018525034A5 (https=)
Quiniou et al. Human thymopoiesis produces polyspecific CD8+ α/β T cells responding to multiple viral antigens
Champagne et al. Adoptive T cell therapy targeting an inducible and broadly shared product of aberrant mRNA translation
Lingdan et al. Differential dissolved protein expression throughout the life cycle of Giardia lamblia
JP2021502110A5 (https=)
WO2025097243A1 (en) Colorectal tumor antigens and uses thereof